Media alert: Fourth Congress of the European Academy of Neurology, 16 – 19 June 2018, Lisbon, Portugal

 The Fourth Congress of the European Academy of Neurology (EAN) will take place at the Lisboa Congress Centre in Lisbon from 16 to 19 June. This major scientific event will attract thousands of participants from European and non-European countries. Broad range of topics In the course of around 80 scientific sessions, international experts will present […]

Continue Reading

EMMA, ENPA, EPC and NME welcome the Agreement of the EU Council on the Publisher’s Right

The European Magazine Media Association (EMMA), the European Newspaper Publishers’ Association (ENPA), the European Publishers’ Council (EPC) and News Media Europe (NME) welcome the fact that the Committee of Permanent Representatives of the Council called for the introduction of an exclusive right for press publishers in EU copyright law today. Although the original proposal from […]

Continue Reading

Klotho and endocrine FGFs: More than markers of CKD progression and cardiovascular complications

Klotho, the Greek goddess who spins the thread of life, has become popular among nephrologists, because the genes named after her encode receptors for hormones that play critical roles in the pathophysiology of chronic kidney disease (CKD). Namely, αKlotho and βKlotho function as receptors for two hormones, fibroblast growth factor-23 (FGF23) and FGF21, respectively.  As […]

Continue Reading

Addressing cardiovascular risk factors can help to improve access to, and outcomes of, kidney transplantation

A review [1] published in Nephrology Dialysis Transplantation (NDT) during the ERA-EDTA Congress in Copenhagen highlights the importance of controlling all metabolic risk factors for cardiovascular disease in every potential kidney transplant candidate, both before and after transplantation. Review author Dr Umberto Maggiore, Parma University Hospital, commented: “By the time the patient is offered a […]

Continue Reading

Shedding a new light: The implication of microRNAs in chronic kidney disease

Development of disease is often related to the deregulation of a gene program controlled at the post-transcriptional level by microRNAs (miRNAs). A new review [1], published in Nephrology Dialysis Transplantation during this week’s ERAEDTA Congress in Copenhagen, shows that miRNAs are potential innovative biomarkers, and are promising as groundbreaking drugs. “The review of Laurent Metzinger […]

Continue Reading

A pre-emptive kidney transplant is still the best option for patients with kidney failure

A new analysis [1], published in Nephrology Dialysis Transplantation during this week’s ERA-EDTA Congress in Copenhagen, confirms that a kidney transplant before start of dialysis extends the life of both the patient and the transplanted organ. However, for patients who do not receive a preemptive transplant, the length of time they spend dialysis (dialysis vintage) […]

Continue Reading

Abatacept for lupus nephritis: no improvement in one year remission rate but faster falls in proteinuria and effects on serologic markers

 Over a third of systemic lupus erythematosus (SLE) patients have kidney involvement (lupus nephritis), and are at risk of end-stage renal disease and premature death. Current therapies are toxic and not routinely effective, so novel therapy options are urgently needed.  At the ERA-EDTA Congress being held this week in Copenhagen, a study [1] will be presented in which […]

Continue Reading

DKK3: A novel diagnostic tool for improving the management of CKD patients and thus to mitigate the future burden of CKD

The prevalence of chronic kidney disease (CKD) is relatively high, at approximately 10% of the population, but only relatively few patients have endstage renal disease and require renal replacement therapy. It is not possible at present to stratify patients reliably according to whether or not their kidney disease is progressing (rapidly). A new biomarker, urinary […]

Continue Reading